Press Releases
Regulatory
May 19, 2022
Egetis Therapeutics raises approximately SEK 180 million through an oversubscribed rights issue
May 6, 2022
Egetis invites shareholders to an informal information meeting
May 5, 2022
Upcoming event
May 30, 2022
Latest presentation
May 17, 2022
Latest Report
April 26, 2022
Calendar and upcoming reports
May 30, 2022
Annual General Meeting
August 19, 2022
Half-year report January - June
November 8, 2022
Interim report January - September
